Literature DB >> 2115041

High concentrations of plasma immunoreactive inhibin during normal pregnancy in women.

Y Abe1, Y Hasegawa, K Miyamoto, M Yamaguchi, A Andoh, Y Ibuki, M Igarashi.   

Abstract

The plasma inhibin concentrations in 190 normal pregnant women at 5-40 weeks gestation and in 4 puerperal women were measured by a specific RIA for human inhibin. The average plasma inhibin concentrations in pregnant women throughout pregnancy (minimum, 2.25 +/- 0.48 IU/mL at 17 weeks gestation; maximum, 24.15 +/- 6.99 IU/mL at 39 weeks gestation) were much higher than those in nonpregnant women with a normal menstrual cycle (0.46 +/- 0.04 IU/mL in the midfollicular phase and 2.02 +/- 0.47 IU/mL in the midluteal phase). The inhibin concentrations were already high at 5 weeks gestation (7.54 +/- 1.10 IU/mL) and rose to peak at 8-10 weeks gestation. The concentrations then decreased and remained relatively low during 14-30 weeks gestation, but rose again during the third trimester. The inhibin concentrations decreased to undetectable levels after delivery. Immunoreactive inhibin was demonstrated in the corpus luteum and term placental extracts, and the dose-response curves were parallel to an inhibin preparation from human follicular fluid. Immunoreactive inhibin concentrations were also high in both the umbilical vein and artery (7.77 +/- 0.80 and 7.84 +/- 0.78 IU/mL, respectively). These observations suggest that both the corpus luteum and placenta are likely sources of inhibin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2115041     DOI: 10.1210/jcem-71-1-133

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  2 in total

1.  Secretion of inhibin A and inhibin B during pregnancy and early postpartum period in Japanese monkeys.

Authors:  Chihiro Kojima; Masahiro Kondo; WanZhu Jin; Keiko Shimizu; Mariko Itoh; Gen Watanabe; N P Groome; Kazuyoshi Taya
Journal:  Endocrine       Date:  2002-06       Impact factor: 3.633

2.  Serum levels of dimeric activin A are not a marker of placental tumors in the course of chemotherapy.

Authors:  P Florio; S Luisi; E Casarosa; A R Genazzani; P Pautier; C Lhommé; J M Bidart; P G Driul; F Petraglia
Journal:  J Endocrinol Invest       Date:  1998-03       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.